Literature DB >> 10823851

H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus.

A Azoulay-Cayla1, S Dethlefs, B Pérarnau, E L Larsson-Sciard, F A Lemonnier, M Brahic, J F Bureau.   

Abstract

H-2(b) mice are resistant to persistent infection of the central nervous system by Theiler's virus. They clear the infection 7 to 10 days after intracranial inoculation. Resistance maps to the H-2D gene and not to the H-2K gene and is associated with a potent antiviral cytotoxic T-lymphocyte (CTL) response. We used H-2(b) mice in which the H-2D or the H-2K gene had been inactivated to dissect the respective roles of these genes in resistance. We report that H-2D(-/-) but not H-2K(-/-) mice were susceptible to persistent infection. Furthermore, whereas H-2K(-/-) mice mounted a vigorous virus-specific CTL response, similar to that of control C57BL/6 mice, the CTL response of H-2D(-/-) mice was nil or minimal. Using target cells transfected with the H-2D(b) or the H-2K(b) gene, we showed that the H-2K-restricted CTL response against the virus was minimal in H-2D(-/-) mice. These results demonstrate that the H-2D(b) and H-2K(b) genes play nonredundant roles in the resistance to this persistent infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823851      PMCID: PMC112031          DOI: 10.1128/jvi.74.12.5470-5476.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Role of the humoral immune response in resistance to Theiler's virus infection.

Authors:  C P Rossi; E Cash; C Aubert; A Coutinho
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation.

Authors:  M Rodriguez; A K Patick; L R Pease
Journal:  J Neuroimmunol       Date:  1990-03       Impact factor: 3.478

4.  The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice.

Authors:  P Borrow; P Tonks; C J Welsh; A A Nash
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

5.  Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus.

Authors:  S Aubagnac; M Brahic; J F Bureau
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Theiler's virus infection of beta 2-microglobulin-deficient mice.

Authors:  L Fiette; C Aubert; M Brahic; C P Rossi
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

Authors:  R J Clatch; R W Melvold; S D Miller; H L Lipton
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.

Authors:  M D Lindsley; M Rodriguez
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

10.  Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

Authors:  M Rodriguez; J Leibowitz; C S David
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  20 in total

1.  Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the beta(2)m gene.

Authors:  S Aubagnac; M Brahic; J F Bureau
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

4.  Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.

Authors:  Yanice V Mendez-Fernandez; Michael J Hansen; Moses Rodriguez; Larry R Pease
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

6.  Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles.

Authors:  Michael A Lyman; Hee-Gu Lee; Bong Su Kang; Hee-Kap Kang; Byung S Kim
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 7.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

8.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

9.  Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases.

Authors:  F Levillayer; M Mas; F Levi-Acobas; M Brahic; J F Bureau
Journal:  Genetics       Date:  2007-05-04       Impact factor: 4.562

10.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.